Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

PEIJIA MEDICAL Aktie

>PEIJIA MEDICAL Aktienkurs

0.7175 EUR (Tradegate)

Ask: 0.735 EUR / 4500 Stück

Bid: 0.7 EUR / 4800 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

PEIJIA MED Aktie über LYNX handeln

Intraday

1 Jahr

>PEIJIA MEDICAL Performance

1 Woche: +1,8%

1 Monat: +11,2%

3 Monate: +23,2%

6 Monate: +48,9%

1 Jahr: +126,3%

laufendes Jahr: +46,7%

>PEIJIA MEDICAL Aktie

Name:

PEIJIA MEDICAL HD -,01

Land:

China

Sektor:

Gesundheit

ISIN/ Wkn:

KYG6981F1090 / A2P4JC

Symbol/ Ticker:

4WO (Frankfurt)

Kürzel:

FRA:4WO, ETR:4WO, 4WO:GR

Index:

Webseite:

http://www.peijiamedical...

Marktkapitalisierung:

452.05 Mio. EUR

Umsatz:

530.84 Mio. EUR

EBITDA:

-152.3 Mio. EUR

Gewinn je Aktie:

-0.034 EUR

Schulden:

218.55 Mio. EUR

Liquide Mittel:

614.53 Mio. EUR

Umsatz-/ Gewinnwachstum:

45.3% / -

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

5.9 / 1.78 / -

Gewinnm./ Eigenkapitalr.:

-36.81% / -10.58%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

PEIJIA MEDICAL, PEIJIA MED

Letzte Datenerhebung:

24.06.25

>PEIJIA MED Eigentümer

Aktien: 665.19 Mio. St.

f.h. Aktien: 416.7 Mio. St.

Insider Eigner: 24.43%

Instit. Eigner: 33.67%

Leerverk. Aktien: -

>PEIJIA MED Peer Group

3SBIO

ABBISKO

HBM HOLDINGS

HYGEIA

KEYMED

PARANOVUS

SHANGHAI HAOHAI

SHANGHAI PHARMACEUTICALS

TONG REN TANG

VIVA BIOTECH

>PEIJIA MEDICAL Chart & Kurs - Tradegate

>PEIJIA MEDICAL News

01.04.25 - 14:01	Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products (PR Newswire)
	SUZHOU, China, April 1, 2025 /PRNewswire/ -- Today, April 1st, Peijia Medical Technology (Suzhou) Co., Ltd. held a strategic innovation cooperation signing ceremony and a press conference to announce the research and development achievements of polymer heart valves using ultra-high......

26.03.25 - 13:03	Peijia Medical Announces 2024 Annual Results (PR Newswire)
	HONG KONG, March 26, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the year ended December 31, 2024 ("the Year") on March 25,......

26.08.24 - 14:31	Peijia Medical Announces 2024 Interim Results (PR Newswire)
	HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months ended June 30, 2024 ("the period") on August......

18.06.24 - 14:02	XFRA : 4WO: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN PEIJIA MEDICAL HD -,01 4WO KYG6981F1090 AB/FROM ONWARDS 18.06.2024 13:40 CET...

17.06.24 - 14:31	Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading (PR Newswire)
	HONG KONG, June 17, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced the publication of its audited financial results for the year ended......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram